# COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

> **NCT04787510** · — · COMPLETED · sponsor: **University Hospital, Ioannina** · enrollment: 50 (actual)

## Conditions studied

- SARS-COV2 Infection
- COVID-19 Disease
- Hospitalized Patients

## Interventions

- **DRUG:** low molecular weight Heparin as standard of care treatment

## Key facts

- **NCT ID:** NCT04787510
- **Lead sponsor:** University Hospital, Ioannina
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-23
- **Primary completion:** 2021-05-23
- **Final completion:** 2021-06-23
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04787510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04787510, "COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04787510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*